
Lotus Pharmaceutical Co Ltd
TWSE:1795

Intrinsic Value
The intrinsic value of one
Lotus Pharmaceutical Co Ltd
stock under the Base Case scenario is
289.95
TWD.
Compared to the current market price of 229 TWD,
Lotus Pharmaceutical Co Ltd
is
Undervalued by 21%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Lotus Pharmaceutical Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Lotus Pharmaceutical Co Ltd
Balance Sheet Decomposition
Lotus Pharmaceutical Co Ltd
Current Assets | 18.1B |
Cash & Short-Term Investments | 6B |
Receivables | 7.7B |
Other Current Assets | 4.4B |
Non-Current Assets | 22B |
Long-Term Investments | 3.6B |
PP&E | 3.7B |
Intangibles | 14B |
Other Non-Current Assets | 777.9m |
Free Cash Flow Analysis
Lotus Pharmaceutical Co Ltd
TWD | |
Free Cash Flow | TWD |
Earnings Waterfall
Lotus Pharmaceutical Co Ltd
Revenue
|
18.6B
TWD
|
Cost of Revenue
|
-7.7B
TWD
|
Gross Profit
|
10.9B
TWD
|
Operating Expenses
|
-4.9B
TWD
|
Operating Income
|
6B
TWD
|
Other Expenses
|
-954.5m
TWD
|
Net Income
|
5.1B
TWD
|
Profitability Score
Profitability Due Diligence
Lotus Pharmaceutical Co Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Score
Lotus Pharmaceutical Co Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Lotus Pharmaceutical Co Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Score
Lotus Pharmaceutical Co Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Lotus Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Lotus Pharmaceutical Co Ltd
is 311.1 TWD
with a low forecast of 303 TWD and a high forecast of 325.5 TWD.
Dividends
Current shareholder yield for Lotus Pharmaceutical Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Lotus Pharmaceutical Co Ltd
stock under the Base Case scenario is
289.95
TWD.
Compared to the current market price of 229 TWD,
Lotus Pharmaceutical Co Ltd
is
Undervalued by 21%.